We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-1.29%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4B
AUM Growth
+$2M
Cap. Flow
+$136M
Cap. Flow %
3.41%
Top 10 Hldgs %
61.19%
Holding
65
New
10
Increased
18
Reduced
13
Closed
11

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$75.6M
2
APTV icon
Aptiv
APTV
+$75.3M
3
FLEX icon
Flex
FLEX
+$55.7M
4
AMZN icon
Amazon
AMZN
+$55.3M
5
FISV
Fiserv Inc
FISV
+$51.4M

Sector Composition

Rank Sector Weight
1 Healthcare 38.12%
2 Technology 21.31%
3 Consumer Discretionary 13.09%
4 Industrials 9.45%
5 Materials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVT icon
26
Clarivate
CLVT
$1.18B
$42.5M 1.06%
4,524,184
+2,133,332
+89% +$27M
BKD icon
27
Brookdale Senior Living
BKD
$3.43B
$42M 1.05%
9,844,673
MSFT icon
28
Microsoft
MSFT
$3.71T
$36.5M 0.91%
156,754
-48,638
-24% -$12.8M
ATVI
29
DELISTED
Activision Blizzard
ATVI
$34.6M 0.87%
465,450
+156,318
+51% +$12.2M
BABA icon
30
Alibaba
BABA
$304B
$33.5M 0.84%
+419,428
New +$40M
LII icon
31
Lennox International
LII
$15.1B
$33.2M 0.83%
+149,208
New +$35.5M
GTM
32
ZoomInfo Technologies
GTM
$1.21B
$31.2M 0.78%
748,710
+440,556
+143% +$18.7M
BKNG icon
33
Booking.com
BKNG
$156B
$30.5M 0.76%
464,725
+314,325
+209% +$23.6M
MYGN icon
34
Myriad Genetics
MYGN
$304M
$27.9M 0.7%
1,461,484
-235,307
-14% -$5.4M
BFLY icon
35
Butterfly Network
BFLY
$2.21B
$25.7M 0.64%
5,464,751
BLCO icon
36
Bausch + Lomb
BLCO
$5.84B
$23.3M 0.58%
+1,516,684
New +$24.1M
EXPE icon
37
Expedia Group
EXPE
$36.8B
$22.3M 0.56%
+238,400
New +$24.3M
SABR icon
38
Sabre
SABR
$886M
$16.1M 0.4%
3,120,869
+137,400
+5% +$916K
EHC icon
39
Encompass Health
EHC
$12.4B
$15.8M 0.4%
349,830
-1,377,605
-80% -$68.9M
QSI icon
40
Quantum-Si Incorporated
QSI
$164M
$14M 0.35%
5,096,972
-153,028
-3% -$489K
EPAM icon
41
EPAM Systems
EPAM
$4.86B
$13.9M 0.35%
38,500
ALIT icon
42
Alight
ALIT
$420M
$12.6M 0.32%
+86,036
New +$13.3M
NOW icon
43
ServiceNow
NOW
$121B
$10.4M 0.26%
+137,500
New +$12.4M
EVLV icon
44
Evolv Technologies
EVLV
$1.07B
$9.87M 0.25%
4,654,111
+1,654,650
+55% +$4.32M
NEWR
45
DELISTED
New Relic, Inc.
NEWR
$9.23M 0.23%
+160,800
New +$9.65M
DMRC icon
46
Digimarc Corp
DMRC
$171M
$7.45M 0.19%
550,000
CELL
47
DELISTED
PhenomeX Inc. Common Stock
CELL
$6.65M 0.17%
2,325,567
BSX icon
48
Boston Scientific
BSX
$71.4B
$6.48M 0.16%
167,213
-728,183
-81% -$29.2M
OHPAU
49
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$4.79M 0.12%
485,001
DNB
50
DELISTED
Dun & Bradstreet
DNB
$3.1M 0.08%
+250,000
New +$3.71M

Similar funds

Glenview Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Glenview Capital Management held 65 positions worth $4B, up 0.05% from $4B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Glenview Capital Management deployed $136M of net new capital in Q3 2022, opening 10 new positions and adding to 18 existing holdings. Its largest new stake was Alibaba: 419,428 shares worth $33.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 43% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Encompass Health, an estimated $68.9M trimmed.

  • Glenview Capital Management's largest Q3 2022 buy was Alibaba: 419,428 shares worth $33.5M.
  • Glenview Capital Management added most to Tenet Healthcare in Q3 2022, an estimated $75.6M increase.
  • Glenview Capital Management's biggest Q3 2022 reduction was Encompass Health, cutting an estimated $68.9M.
  • Glenview Capital Management fully exited Change Healthcare Inc. Common Stock in Q3 2022, selling an estimated $99.8M.
  • Glenview Capital Management's ten largest holdings make up 61% of its $4B portfolio in Q3 2022.
  • Glenview Capital Management opened 10 new positions and closed 11 in Q3 2022.
  • Glenview Capital Management's portfolio value rose 0.05% quarter-over-quarter to $4B.

Based on Glenview Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.